Seeded propagation of α-synuclein aggregation in mouse brain using protein misfolding cyclic amplification.


Journal

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484

Informations de publication

Date de publication:
11 2019
Historique:
pubmed: 3 8 2019
medline: 9 6 2020
entrez: 3 8 2019
Statut: ppublish

Résumé

α-Synuclein (α-syn) protein aggregation is associated with several neurodegenerative disorders collectively referred to as synucleinopathies, including Parkinson's disease. We used protein misfolding cyclic amplification (PMCA) to study α-syn aggregation in brain homogenates of wild-type or transgenic mice expressing normal (D line) or A53T mutant (M83 line) human α-syn. We found that sonication-incubation cycles of M83 mouse brain gradually produce large quantities of SDS-resistant α-syn aggregates, involving both human and mouse proteins. These PMCA products, containing partially proteinase K-resistant α-syn species, are competent to accelerate the onset of neurologic symptoms after intracerebral inoculation to young M83 mice and to seed aggregate formation of α-syn following PMCA, including in D and wild-type mouse brain substrates. PMCA seeding activity in the M83 diseased brain correlates positively with regions mostly targeted by the α-syn pathology in this model. Our data indicate that similar to prions, PMCA can reproduce some characteristics of α-syn aggregation and seeded propagation

Identifiants

pubmed: 31370680
doi: 10.1096/fj.201900354R
pmc: PMC6902716
doi:

Substances chimiques

Protein Aggregates 0
alpha-Synuclein 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

12073-12086

Références

Exp Mol Med. 2017 Apr 7;49(4):e314
pubmed: 28386127
J Neuropathol Exp Neurol. 2014 Dec;73(12):1144-51
pubmed: 25383638
Nature. 2016 Nov 09;539(7628):227-235
pubmed: 27830791
Acta Neuropathol Commun. 2019 May 20;7(1):80
pubmed: 31109378
Nat Commun. 2013;4:2575
pubmed: 24108358
Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):20051-6
pubmed: 19892735
Nature. 2018 May;557(7706):558-563
pubmed: 29743672
J Biol Chem. 2019 Jun 7;294(23):9016-9028
pubmed: 31064841
Front Neurol. 2018 Jun 06;9:415
pubmed: 29928254
Ann Neurol. 2019 May;85(5):691-703
pubmed: 30805957
Hum Mol Genet. 2017 Dec 15;26(24):4906-4915
pubmed: 29036344
Mol Neurodegener. 2013 Jan 22;8:5
pubmed: 23339399
Sci Transl Med. 2016 Dec 21;8(370):370ra182
pubmed: 28003547
Cell. 2005 Apr 22;121(2):195-206
pubmed: 15851027
Neurobiol Dis. 2019 Sep;129:38-43
pubmed: 31078683
Acta Neuropathol. 2018 Jan;135(1):49-63
pubmed: 28849371
J Virol. 2017 Jan 3;91(2):
pubmed: 27852849
BMC Neurosci. 2001;2:11
pubmed: 11591219
J Neurosci. 2010 Mar 3;30(9):3409-18
pubmed: 20203200
PLoS Genet. 2014 Nov 13;10(11):e1004741
pubmed: 25393002
J Virol. 2018 Aug 29;92(18):
pubmed: 29976670
J Exp Med. 2012 May 7;209(5):975-86
pubmed: 22508839
Nature. 2001 Jun 14;411(6839):810-3
pubmed: 11459061
Biochemistry. 2003 Jan 28;42(3):829-37
pubmed: 12534296
Science. 2000 Feb 18;287(5456):1265-9
pubmed: 10678833
Cell Tissue Res. 2018 Jul;373(1):161-173
pubmed: 29480459
Acta Neuropathol Commun. 2014 Mar 13;2:29
pubmed: 24624994
Brain. 2018 Aug 1;141(8):2419-2431
pubmed: 29917054
Neurobiol Aging. 2012 Sep;33(9):2225-8
pubmed: 21813214
Proc Natl Acad Sci U S A. 2016 Sep 13;113(37):10328-33
pubmed: 27573854
J Neurochem. 2017 Oct;143(1):126-135
pubmed: 28771723
Neuron. 2002 May 16;34(4):521-33
pubmed: 12062037
Nature. 2015 Jun 18;522(7556):340-4
pubmed: 26061766
Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):E5308-17
pubmed: 26324905
J Am Chem Soc. 2011 Aug 31;133(34):13465-70
pubmed: 21721555
J Vis Exp. 2015 May 30;(99):e52752
pubmed: 26068223
Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):10732-7
pubmed: 25002524
Ann Clin Transl Neurol. 2016 Aug 28;3(10):812-818
pubmed: 27752516
J Biol Chem. 2014 Apr 25;289(17):11897-11905
pubmed: 24584936
Acta Neuropathol. 2019 Oct;138(4):515-533
pubmed: 31230104
J Virol. 2016 Sep 29;90(20):9182-93
pubmed: 27489279
Nat Med. 1998 Nov;4(11):1318-20
pubmed: 9809558
Curr Opin Pharmacol. 2019 Feb;44:1-7
pubmed: 30412823
Mol Neurobiol. 2018 Nov;55(11):8728-8737
pubmed: 29589283
JAMA Neurol. 2017 Feb 01;74(2):163-172
pubmed: 27918765
Proc Natl Acad Sci U S A. 2013 Nov 26;110(48):19555-60
pubmed: 24218576
J Biol Chem. 2019 Jul 5;294(27):10392-10406
pubmed: 31142553
Acta Neuropathol. 2014 May;127(5):645-65
pubmed: 24659240

Auteurs

Simon Nicot (S)

Pathogenesis and Control of Chronic Infections, Etablissement Français du Sang, INSERM, Université de Montpellier, Montpellier, France.

Jérémy Verchère (J)

French Agency for Food, Environmental, and Occupational Health and Safety (ANSES), University of Lyon, Lyon, France.

Maxime Bélondrade (M)

Pathogenesis and Control of Chronic Infections, Etablissement Français du Sang, INSERM, Université de Montpellier, Montpellier, France.

Charly Mayran (C)

Pathogenesis and Control of Chronic Infections, Etablissement Français du Sang, INSERM, Université de Montpellier, Montpellier, France.

Dominique Bétemps (D)

French Agency for Food, Environmental, and Occupational Health and Safety (ANSES), University of Lyon, Lyon, France.

Daisy Bougard (D)

Pathogenesis and Control of Chronic Infections, Etablissement Français du Sang, INSERM, Université de Montpellier, Montpellier, France.

Thierry Baron (T)

French Agency for Food, Environmental, and Occupational Health and Safety (ANSES), University of Lyon, Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH